Clinical Trial Update: Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis [NA]

View source ↗

Summary

This document reports on a completed clinical trial studying inflammatory mediators, prognostic markers, and genetic polymorphisms in patients with sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Sepsis | NA | Status: COMPLETED